Skip to main content
Erschienen in: Strahlentherapie und Onkologie 2/2024

05.10.2023 | Original Article

Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002)

verfasst von: Halil Cumhur Yıldırım, M.D, Fazilet Öner Dinçbaş, Volkan Demircan, Murat Beyzadeoğlu, Ertuğrul Tekçe, Gözde Yazıcı, Menekşe Turna, Oğuz Çetinayak, Kudret Ensarioğlu Baktır, Mustafa Akın, Emine Canyılmaz, Ayse Altınok, Ela Delikgöz Soykut, Müge Akmansu, Fuzuli Tuğrul, Seda Ünverdi, Berrin Benli Yavuz, Serra Kamer, Mürsel Düzova, Sumerya Duru Birgi, Emine Elif Özkan, Berrin Yalçın, Merve Şahin, Durmuş Etiz, Hasan Suat Arslantaş, Deniz Meydan, Şefik İğdem, Halil Sağınç, Murtaza Parvizi, Pelin Altınok, Yavuz Anacak

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to investigate the patterns of radiotherapy (RT) care in cases of benign diseases in Turkey.

Methods

A questionnaire survey was sent to all radiation oncology (RO) departments in Turkey. The number of patients treated for benign disease between 2015 and 2020 was requested. A list of benign conditions was given, and information on the number of patients per disease, single and total doses prescribed, weekly fractions, radiation type, energy, and device was requested.

Results

Of the 138 RO departments, 29 (21%) responded. The data received concerned 15 (52%) university, 10 (34%) public, and four (14%) private hospitals. A total of 130,846 patients were treated with RT in these departments. Of these patients, 6346 (4.85%) were treated for benign conditions. The most common benign diseases treated with RT were meningioma (35%), plantar fasciitis (19%), schwannoma (16%), arteriovenous malformation (11%), and pituitary adenoma (7%). Most centers performed RT for paraganglioma, heterotopic ossification, vertebral hemangioma, and Graves’ ophthalmopathy, but none treated arthrosis. Wide variations were observed across the departments. Radiosurgery for intracranial pathologies was performed intensively in four centers. By contrast, RT for plantar fasciitis was predominantly treated in five centers, one of which had more than 1000 patients.

Conclusion

The ratio of patients who underwent RT for benign diseases in Turkey among all patients who underwent RT was 4.85%. The common pattern of RT in 72% of patients was radiosurgery for intracranial benign diseases, followed by low-dose RT for plantar fasciitis in 19%.
Literatur
1.
Zurück zum Zitat Seegenschmiedt MH, Micke O, Muecke R, German Cooperative Group on Radiotherapy for Non-malignant Diseases (GCG-BD) (2015) Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines. Br J Radiol 88(1051):20150080. https://doi.org/10.1259/bjr.20150080 (Erratum in: Br J Radiol. 2015;88(1056):20159003)CrossRefPubMedPubMedCentral Seegenschmiedt MH, Micke O, Muecke R, German Cooperative Group on Radiotherapy for Non-malignant Diseases (GCG-BD) (2015) Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines. Br J Radiol 88(1051):20150080. https://​doi.​org/​10.​1259/​bjr.​20150080 (Erratum in: Br J Radiol. 2015;88(1056):20159003)CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Reichl B, Block A, Schäfer U, Bert C, Müller R, Jung H, Rödel F, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) (2015) DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk. Strahlenther Onkol 191(9):701–709. https://doi.org/10.1007/s00066-015-0865-8CrossRefPubMed Reichl B, Block A, Schäfer U, Bert C, Müller R, Jung H, Rödel F, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) (2015) DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk. Strahlenther Onkol 191(9):701–709. https://​doi.​org/​10.​1007/​s00066-015-0865-8CrossRefPubMed
4.
Zurück zum Zitat Ott OJ, Niewald M, Weitmann HD, Jacob I, Adamietz IA, Schaefer U, Keilholz L, Heyd R, Muecke R, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) (2015) DEGRO guidelines for the radiotherapy of non-malignant disorders. Part II: Painful degenerative skeletal disorders. Strahlenther Onkol 191(1):1–6. https://doi.org/10.1007/s00066-014-0757-3CrossRefPubMed Ott OJ, Niewald M, Weitmann HD, Jacob I, Adamietz IA, Schaefer U, Keilholz L, Heyd R, Muecke R, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) (2015) DEGRO guidelines for the radiotherapy of non-malignant disorders. Part II: Painful degenerative skeletal disorders. Strahlenther Onkol 191(1):1–6. https://​doi.​org/​10.​1007/​s00066-014-0757-3CrossRefPubMed
5.
Zurück zum Zitat Seegenschmiedt MH, Micke O, Niewald M, Mücke R, Eich HT, Kriz J, Heyd R, German Cooperative Group on Radiotherapy of Benign Diseases (GCG-BD) (2015) DEGRO guidelines for the radiotherapy of non-malignant disorders : part III: hyperproliferative disorders. Strahlenther Onkol 191(7):541–548. https://doi.org/10.1007/s00066-015-0818-2CrossRefPubMed Seegenschmiedt MH, Micke O, Niewald M, Mücke R, Eich HT, Kriz J, Heyd R, German Cooperative Group on Radiotherapy of Benign Diseases (GCG-BD) (2015) DEGRO guidelines for the radiotherapy of non-malignant disorders : part III: hyperproliferative disorders. Strahlenther Onkol 191(7):541–548. https://​doi.​org/​10.​1007/​s00066-015-0818-2CrossRefPubMed
9.
Zurück zum Zitat The Royal College of Radiologists (2015) A review of the use of radiotherapy in the UK for the treatment of benign clinical conditions and benign tumours. The Royal College of Radiologists, London The Royal College of Radiologists (2015) A review of the use of radiotherapy in the UK for the treatment of benign clinical conditions and benign tumours. The Royal College of Radiologists, London
10.
Zurück zum Zitat The Royal College of Radiologists (2023) Recommendations for using radiotherapy for benign disease in the UK. The Royal College of Radiologists, London The Royal College of Radiologists (2023) Recommendations for using radiotherapy for benign disease in the UK. The Royal College of Radiologists, London
12.
Zurück zum Zitat Alvarez B, Montero A, Hernando O, Ciervide R, Garcia J, Lopez M, Garcia-Aranda M, Chen X, Flores I, Sanchez E, Valero J, Prado A, Alonso R, Alonso L, Fernandez-Leton P, Rubio C (2021) Radiotherapy CT-based contouring atlas for non-malignant skeletal and soft tissue disorders: a practical proposal from Spanish experience. Br J Radiol 94(1124):20200809. https://doi.org/10.1259/bjr.20200809CrossRefPubMedPubMedCentral Alvarez B, Montero A, Hernando O, Ciervide R, Garcia J, Lopez M, Garcia-Aranda M, Chen X, Flores I, Sanchez E, Valero J, Prado A, Alonso R, Alonso L, Fernandez-Leton P, Rubio C (2021) Radiotherapy CT-based contouring atlas for non-malignant skeletal and soft tissue disorders: a practical proposal from Spanish experience. Br J Radiol 94(1124):20200809. https://​doi.​org/​10.​1259/​bjr.​20200809CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Beyzadeoğlu M, Sager Ö, Dıncoglan F, Demiral S, Uysal B, Gamsız H, Özcan F, Çolak O, Dirican B (2020) Evaluation of the radiotherapeutic management of refractory painful heel spur and plantar fasciitis: a single center experience of 45 years. Gülhane Tıp Derg 62(1):8–13. https://doi.org/10.4274/gulhane.galenos.2019.730CrossRef Beyzadeoğlu M, Sager Ö, Dıncoglan F, Demiral S, Uysal B, Gamsız H, Özcan F, Çolak O, Dirican B (2020) Evaluation of the radiotherapeutic management of refractory painful heel spur and plantar fasciitis: a single center experience of 45 years. Gülhane Tıp Derg 62(1):8–13. https://​doi.​org/​10.​4274/​gulhane.​galenos.​2019.​730CrossRef
22.
Zurück zum Zitat Agdoğan Ö, Tosun U (2019) Bir Tarım Coğrafyası Olan Trakya’ da Dupuytren Hastalığı’ nın Epidemiyolojik Profilinin İncelenmesi. NKMJ 7(2):77–82 Agdoğan Ö, Tosun U (2019) Bir Tarım Coğrafyası Olan Trakya’ da Dupuytren Hastalığı’ nın Epidemiyolojik Profilinin İncelenmesi. NKMJ 7(2):77–82
24.
Zurück zum Zitat Mahler EAM, Minten MJ, Leseman-Hoogenboom MM, Poortmans PMP, Leer JWH, Boks SS, van den Hoogen FHJ, den Broeder AA, van den Ende CHM (2019) Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis: a randomised, double-blinded, sham-controlled trial. Ann Rheum Dis 78(1):83–90. https://doi.org/10.1136/annrheumdis-2018-214104CrossRefPubMed Mahler EAM, Minten MJ, Leseman-Hoogenboom MM, Poortmans PMP, Leer JWH, Boks SS, van den Hoogen FHJ, den Broeder AA, van den Ende CHM (2019) Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis: a randomised, double-blinded, sham-controlled trial. Ann Rheum Dis 78(1):83–90. https://​doi.​org/​10.​1136/​annrheumdis-2018-214104CrossRefPubMed
25.
Zurück zum Zitat Minten MJM, Leseman-Hoogenboom MM, Kloppenburg M, Kortekaas MC, Leer JW, Poortmans PMP, van den Hoogen FHJ, den Broeder AA, van den Ende CHM (2018) Lack of beneficial effects of low-dose radiation therapy on hand osteoarthritis symptoms and inflammation: a randomised, blinded, sham-controlled trial. Osteoarthritis Cartilage 26(10):1283–1290. https://doi.org/10.1016/j.jocaCrossRefPubMed Minten MJM, Leseman-Hoogenboom MM, Kloppenburg M, Kortekaas MC, Leer JW, Poortmans PMP, van den Hoogen FHJ, den Broeder AA, van den Ende CHM (2018) Lack of beneficial effects of low-dose radiation therapy on hand osteoarthritis symptoms and inflammation: a randomised, blinded, sham-controlled trial. Osteoarthritis Cartilage 26(10):1283–1290. https://​doi.​org/​10.​1016/​j.​jocaCrossRefPubMed
26.
Zurück zum Zitat de Haan A, van Nes JGH, Kolff MW, van der Toorn PP, Westenberg AH, van der Vegt AE, Groen H, Overbosch J, van der Laan HP, Werker PMN, Langendijk JA, Steenbakkers RJHM (2023) Radiotherapy for Ledderhose disease: results of the LedRad-study, a prospective multicentre randomised double-blind phase 3 trial. Radiother Oncol 185:109718. https://doi.org/10.1016/j.radonc.2023.109718CrossRefPubMed de Haan A, van Nes JGH, Kolff MW, van der Toorn PP, Westenberg AH, van der Vegt AE, Groen H, Overbosch J, van der Laan HP, Werker PMN, Langendijk JA, Steenbakkers RJHM (2023) Radiotherapy for Ledderhose disease: results of the LedRad-study, a prospective multicentre randomised double-blind phase 3 trial. Radiother Oncol 185:109718. https://​doi.​org/​10.​1016/​j.​radonc.​2023.​109718CrossRefPubMed
Metadaten
Titel
Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002)
verfasst von
Halil Cumhur Yıldırım, M.D
Fazilet Öner Dinçbaş
Volkan Demircan
Murat Beyzadeoğlu
Ertuğrul Tekçe
Gözde Yazıcı
Menekşe Turna
Oğuz Çetinayak
Kudret Ensarioğlu Baktır
Mustafa Akın
Emine Canyılmaz
Ayse Altınok
Ela Delikgöz Soykut
Müge Akmansu
Fuzuli Tuğrul
Seda Ünverdi
Berrin Benli Yavuz
Serra Kamer
Mürsel Düzova
Sumerya Duru Birgi
Emine Elif Özkan
Berrin Yalçın
Merve Şahin
Durmuş Etiz
Hasan Suat Arslantaş
Deniz Meydan
Şefik İğdem
Halil Sağınç
Murtaza Parvizi
Pelin Altınok
Yavuz Anacak
Publikationsdatum
05.10.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 2/2024
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-023-02154-x

Weitere Artikel der Ausgabe 2/2024

Strahlentherapie und Onkologie 2/2024 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.